Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.
Celeste Krewson
Advertisement
Articles by Celeste Krewson
Following the statewide order in August 2022, emergency contraceptive fills at Massachusetts pharmacies increased by 32% compared with rates in other states.
The unanimous ruling maintains nationwide access to mifepristone for medical abortion, reversing a lower court's decision to restrict availability.
Details on educational gaps, vaccination rates, and the importance of an open dialogue between patients and clinicians, here.
Advertisement
Latest Updated Articles
FDA Approves Femlyv, First Orally Disintegrating Tablet for Birth ControlPublished: July 25th 2024 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
2
Semaglutide CV Effects Appear Independent of Baseline Adiposity, Suggesting Disease-Modifying Potential
3
APOE ε4 and Inflammation Amplify Risk for Memory Decline in Women with Earlier Menopause
4
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
5
